Kamaljit Kaur

10PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsGlycoconjugatesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2026
Receptor-Mediated Drug Delivery: Redefining Targeted Drug Conjugates in Oncology.

Keon Niles Jafari, Charlene Chai, Shelby Kim

|Jul 02, 2025
Surface keratin 1, a tumor-selective peptide target in human triple-negative breast cancer.

Shih-Jing Yao, Farideh Amirrad, Elmira Ziaei

|Jan 15, 2025
A Conjugate of an EGFR-Binding Peptide and Doxorubicin Shows Selective Toxicity to Triple-Negative Breast Cancer Cells.

Phi-Phung Than, Shih-Jing Yao, Emad Althagafi

|Jun 12, 2023
Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice.

Elmira Ziaei, Igor Moura de Paiva, Shih-Jing Yao

|May 28, 2022
A Small Peptide Increases Drug Delivery in Human Melanoma Cells.

Shirley Tong, Shaban Darwish, Hanieh Hossein Nejad Ariani

Pageof 2